BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21046151)

  • 1. Expression and localization of E-cadherin and β-catenin in uterine carcinosarcoma.
    Nishimura I; Ohishi Y; Oda Y; Kishimoto J; Yasunaga M; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
    Virchows Arch; 2011 Jan; 458(1):85-94. PubMed ID: 21046151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.
    Inoue H; Takahashi H; Hashimura M; Eshima K; Akiya M; Matsumoto T; Saegusa M
    BMC Cancer; 2016 Feb; 16():53. PubMed ID: 26841870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of the Akt/beta-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of slug.
    Saegusa M; Hashimura M; Kuwata T; Okayasu I
    Am J Pathol; 2009 Jun; 174(6):2107-15. PubMed ID: 19389926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of adhesion molecules and the proliferative activity of carcinosarcoma of the ovary.
    Hirano H; Kizaki T; Ito T; Okimura A; Yamanegi K; Nakasho K
    Anticancer Res; 2014 Dec; 34(12):7351-6. PubMed ID: 25503171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.
    Etoh T; Nakai H
    J Obstet Gynaecol Res; 2014 Mar; 40(3):820-5. PubMed ID: 24320058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report.
    Semczuk A; Skomra D; Chyzyńska M; Szewczuk W; Olcha P; Korobowicz E
    Pathol Res Pract; 2008; 204(3):203-7. PubMed ID: 18207653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the sarcomatous component (homologous vs heterologous) the prognostic "driving force" in early-stage uterine carcinosarcomas? A retrospective multicenter study.
    Rosati A; Vargiu V; Certelli C; Arcieri M; Vizza E; Legge F; Cosentino F; Ferrandina G; Fanfani F; Scambia G; Corrado G
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6479-6488. PubMed ID: 36773091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of ALK-related signal cascades on modulation of epithelial-mesenchymal transition and apoptosis in uterine carcinosarcoma.
    Inoue H; Hashimura M; Akiya M; Chiba R; Saegusa M
    Mol Cancer; 2017 Feb; 16(1):37. PubMed ID: 28193280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line.
    Stockhammer P; Okumus Ö; Hegedus L; Rittler D; Ploenes T; Herold T; Kalbourtzis S; Bankfalvi A; Sucker A; Kimmig R; Aigner C; Hegedus B
    Pathol Oncol Res; 2021; 27():636088. PubMed ID: 34257602
    [No Abstract]   [Full Text] [Related]  

  • 10. E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.
    Li L; Zhang Z; Li B; Gao F; Li L; Jonas JB
    Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1867-73. PubMed ID: 21739269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
    Costa MJ; Guinee D
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT, EGFR, C-ErbB-2, and C-kit expression in uterine carcinosarcoma.
    Saglam O; Husain S; Toruner G
    Int J Gynecol Pathol; 2013 Sep; 32(5):493-500. PubMed ID: 23896716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX8 expression in uterine malignant mesodermal mixed tumor (carcinosarcoma).
    Holmes BJ; Gown AM; Vang R; Ronnett BM; Yemelyanova A
    Int J Gynecol Pathol; 2014 Jul; 33(4):425-31. PubMed ID: 24901404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of β-catenin and E-cadherin expression in Dukes B2 stage colorectal cancer with tissue microarray method. Is it a marker of metastatic potential in rectal cancer?
    Tóth L; András C; Molnár C; Tanyi M; Csiki Z; Molnár P; Szántó J
    Pathol Oncol Res; 2012 Apr; 18(2):429-37. PubMed ID: 21975680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
    Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic and molecular features of uterine carcinosarcomas.
    Lopez-Garcia MA; Palacios J
    Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.
    Matsuo K; Takazawa Y; Ross MS; Elishaev E; Yunokawa M; Sheridan TB; Bush SH; Klobocista MM; Blake EA; Takano T; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Yanai S; Takeuchi S; Nishimura M; Iwasaki K; Johnson MS; Yoshida M; Hakam A; Machida H; Mhawech-Fauceglia P; Ueda Y; Yoshino K; Kajiwara H; Hasegawa K; Yasuda M; Miyake TM; Moriya T; Yuba Y; Morgan T; Fukagawa T; Pejovic T; Nagano T; Sasaki T; Richmond AM; Post MD; Shahzad MMK; Im DD; Yoshida H; Enomoto T; Omatsu K; Ueland FR; Kelley JL; Karabakhtsian RG; Roman LD
    Ann Surg Oncol; 2018 Sep; 25(9):2756-2766. PubMed ID: 29971677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cadherin-catenin complex in nasopharyngeal carcinoma.
    Galera-Ruiz H; Ríos MJ; González-Cámpora R; de Miguel M; Carmona MI; Moreno AM; Galera-Davidson H
    Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1335-41. PubMed ID: 21240516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma.
    Moon KC; Cho SY; Lee HS; Jeon YK; Chung JH; Jung KC; Chung DH
    Arch Pathol Lab Med; 2006 Sep; 130(9):1320-5. PubMed ID: 16948518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.